RSV vaccination for expectant moms and newborns
Thanks to vaccines that are now available to both expectant moms and infants, families have access to more protection than ever before.
To prevent severe RSV disease in infants, expectant mothers can choose to receive the RSV vaccine when they are between 32 and 36 weeks pregnant to prevent lower respiratory tract disease (LRTD) caused by RSV in infants from birth through 6 months of age.
If mothers did not receive the RSV vaccine during pregnancy, there is also a preventive monoclonal antibody treatment called nirsevimab that LVHN offers to all newborns. Most infants will not need both maternal vaccination and infant RSV antibodies.
Infant RSV antibodies are highly effective in preventing RSV-associated hospitalization. The optimal timing for infant RSV antibody administration is shortly before the RSV season begins (October through November), or within a baby's first week of life, if they are born in October through March (ideally during birth hospitalization).
If you have any questions, talk to your doctor about protecting your infant against RSV this season.